Nora Jee-Young Park Selected Research

Neoplasms (Cancer)

4/2024	Long non-coding RNA SOX2OT in tamoxifen-resistant breast cancer.
1/2024	Improving Tumor-Infiltrating Lymphocytes Score Prediction in Breast Cancer with Self-Supervised Learning.
11/2023	Comparison of immunohistochemistry and next-generation sequencing results in oncogenic PTEN missense mutations.
4/2023	Validation and Clinical Application of ONCOaccuPanel for Targeted Next-Generation Sequencing of Solid Tumors.
1/2023	Transcriptomic Network Analysis Using Exfoliative Cervical Cells Could Discriminate a Potential Risk of Progression to Cancer in HPV-related Cervical Lesions: A Pilot Study.
10/2022	Immune Pathway and Gene Database (IMPAGT) Revealed the Immune Dysregulation Dynamics and Overactivation of the PI3K/Akt Pathway in Tumor Buddings of Cervical Cancer.
7/2022	Strategic Significance of Low Viral Load of Human Papillomavirus in Uterine Cervical Cytology Specimens.
5/2022	Survival Impact of Residual Cancer Cells in Intraoperative Peritoneal Washes following Radical Hysterectomy for Cervical Cancer.
5/2022	Clinical Utility of Next-generation Sequencing in Real-world Cases: A Single-institution Study of Nine Cases.
1/2022	Transcriptomic Immune Profiles Can Represent the Tumor Immune Microenvironment Related to the Tumor Budding Histology in Uterine Cervical Cancer.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nora Jee-Young Park Research Topics

Disease

12	Neoplasms (Cancer) 04/2024 - 08/2021
7	Breast Neoplasms (Breast Cancer) 04/2024 - 04/2021
7	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2023 - 01/2021
2	Triple Negative Breast Neoplasms 01/2024 - 12/2022
2	Thyroid Neoplasms (Thyroid Cancer) 03/2023 - 01/2022
1	Rectal Neoplasms (Rectal Cancer) 04/2023
1	Carcinogenesis 01/2023
1	Pathologic Complete Response 12/2022
1	Calcinosis 12/2022
1	Residual Neoplasm 05/2022
1	Lymphatic Metastasis 05/2022
1	Metaplasia 02/2022
1	Atrophy 02/2022
1	Adrenogenital Syndrome 02/2022
1	Brain Injuries (Brain Injury) 01/2022
1	Anaplastic Thyroid Carcinoma 01/2022
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Ischemic Stroke 01/2021
1	Myocardial Infarction 01/2021
1	Stroke (Strokes) 01/2021
1	Peripheral Arterial Disease 01/2021

Drug/Important Bio-Agent (IBA)

6	Biomarkers (Surrogate Marker)IBA 01/2024 - 01/2021
2	Messenger RNA (mRNA)IBA 01/2024 - 04/2021
1	Long Noncoding RNAIBA 04/2024
1	Phenobarbital (Luminal)FDA Link 04/2024
1	Tamoxifen FDA LinkGeneric 04/2024
1	Hormones (Hormone)IBA 04/2024
1	RNA (Ribonucleic Acid)IBA 01/2024
1	OTS167IBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 11/2023
1	TensinsIBA 11/2023
1	NucleotidesIBA 04/2023
1	Formaldehyde (Formol)FDA Link 04/2023
1	ParaffinIBA 04/2023
1	Telomerase (Telomerase Reverse Transcriptase)IBA 03/2023
1	Proteoglycans (Proteoglycan)IBA 01/2023
1	ErbB Receptors (EGF Receptor)IBA 12/2022
1	DNA (Deoxyribonucleic Acid)IBA 07/2022
1	Estrogen ReceptorsIBA 02/2022
1	Androstenedione (4 Androstene 3,17 dione)IBA 02/2022
1	Testosterone (Sustanon)FDA Link 02/2022
1	EnzymesIBA 02/2022
1	AndrogensIBA 02/2022
1	Transcription Factors (Transcription Factor)IBA 02/2022
1	Androgen Receptors (Androgen Receptor)IBA 02/2022
1	prolinedithiocarbamate (PDTC)IBA 01/2022
1	Nucleic AcidsIBA 01/2022
1	GadoliniumIBA 10/2021
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 08/2021
1	P-SelectinIBA 01/2021

Therapy/Procedure

4	Lymph Node Excision (Lymph Node Dissection) 08/2023 - 01/2021
4	Neoadjuvant Therapy 04/2023 - 01/2022
4	Hysterectomy 05/2022 - 01/2021
2	Therapeutics 10/2022 - 05/2022
1	Immunotherapy 01/2024
1	Precision Medicine 08/2021